Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06616116. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06616116
Stress Management with Real-time Bio-signal Biofeedback
This study is recruiting. It focuses on bipolarity and currently lists participation information in South Korea.
BipolarityOtherFrom 15 Years to 59 Years
Key information made simple
This study is looking at whether Biosignal feedback can help people with bipolarity or Major Depressive Diorder. Participants take part in Biosignal feedback and complete follow-up assessments. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a hospital, with sites including Seoul National University Hospital. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include safety concerns that need urgent care first and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Seoul National University Hospital
- Sponsor type
- Hospital / academic medical center
- Main activity
- medication or study treatment
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Stress Management with Real-time Bio-signal Biofeedback
- Condition
- Bipolarity (BD); Major Depressive Diorder
- Study status
- Recruiting
- Sponsor / lead affiliation
- Seoul National University Hospital
- Location / country
- South Korea
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06616116
Why this study may matter
This study may matter because it adds public evidence around bipolarity. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in South Korea.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Stress Management with Real-time Bio-signal Biofeedback
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06616116
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Stress Management with Real-time Bio-signal Biofeedback?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a sham comparison. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Seoul National University Hospital. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me